Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

932P - Impact of geriatric assessment on the management of older head and neck cancer patients

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Head and Neck Cancers

Presenters

Maria Plana

Citation

Annals of Oncology (2020) 31 (suppl_4): S599-S628. 10.1016/annonc/annonc277

Authors

M. Plana1, M. Taberna1, S. Llop1, M. Honorato2, E. Vilajosana1, I. Linares3, O. Bermejo4, L. Arribas5, A. Lozano6, J. Nogués7, R. Mesía8, M. Antonio9

Author affiliations

  • 1 Medical Oncology, Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), 08908 - Hospitalet de Llobregat/ES
  • 2 Geriatrics Department, Clinica Alemana de Santiago de Chile, Santiago de Chile/CL
  • 3 Radiation Oncology, Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), 08908 - Hospitalet de Llobregat/ES
  • 4 Plastic Surgery Unit, Hospital Universitari de Bellvitge, Hospitalet de Llobregat/ES
  • 5 Clinical Nutrition Unit, Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), 08908 - Hospitalet de Llobregat/ES
  • 6 Radiation Oncology, Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), Hospitalet de Llobregat/ES
  • 7 Department Of Otorhinolaryngology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat/ES
  • 8 Medical Oncology, Institut Català d'Oncologia Badalona (Hospital Germans Trias i Pujol), Badalona/ES
  • 9 Oncohematogeriatrics Unit, Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), Hospitalet de Llobregat/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 932P

Background

Population’s aging leads to an increased diagnosis of head and neck cancer (HNC) in older patients (pts). Treatment can involve surgery, radiation, systemic therapy or multimodal therapy. Due to heterogeneity of older pts, the comprehensive geriatric assessment (CGA) is considered the gold standard tool to classify pts according to frailty profile. Multidisciplinary approach including a geriatrician is essential. CGA may be helpful to personalize treatment plan and to detect geriatric conditions that can be reversible through geriatric interventions. We aim to evaluate the impact of CGA on therapeutic decisions.

Methods

Pts presented at the mutidisciplinary team meeting aged>70 years were prospectively included. All pts underwent CGA by a geriatrician including validated instruments to assess comorbidity, polypharmacy, functional status, geriatric syndromes, mood, cognition and social status. According to CGA pts were classified in 3 frailty groups: “fit”, “medium fit” and “unfit”. We compared the standard treatment plan according to cancer stage with the one based on CGA classification.

Results

From January 2018 to March 2020, 124 pts were included. Median age was 80 years (range 71-96) and 87 (70.2%) were men. Primary site included oral cavity 38 (30.6%), larynx 33 (26.6%), oropharynx 11 (8.9%), hypopharynx 10 (8.1%), others 32 (25.7%). Twenty pts (16.2%) had initial stages (I-II), 90 (72.5%) locally advanced (LA) (III to IVb) and 14 (11,3%) recurrent or metastatic disease (R/M). Based on CGA, 55 (44.4%) were classified as fit, 47 (37.9%) as medium fit and 22 (17.7%) as unfit. In up to 33.1% of pts, CGA led to a change in therapy intention, mainly involving LA disease in 78% compared to 4.9% in initial stages and 17.1% in R/M. Seventy-eight (62.9%) received geriatric intervention, mostly (39.7%) in medium fit group. Those interventions where physiotherapy, psychological and nutritional support, and polypharmacy in 21.1%, 14.8%, 37.9% and 41,5% of pts respectively.

Conclusions

Selecting older pts with HNC for standard or adjusted treatment remains a great challenge. Incorporation of CGA within multidisciplinary approach brings the opportunity to better classify pts according to frailty profiles so as to guide interventions and treatment decisions.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.